We are live on ! Find out more
AACR

ACR Alpine Capital Research Portfolio holdings

AUM $7.04B
1-Year Est. Return 28%
This Fund
S&P 500
This Quarter Est. Return
+3.4%
1 Year Est. Return
+28%
3 Year Est. Return
+58.09%
5 Year Est. Return
+55.24%
10 Year Est. Return
+208.51%
AUM
$670M
AUM Growth
+$16.4M
Cap. Flow
-$8.5M
Cap. Flow %
-1.27%
Top 10 Hldgs %
88.77%
Holding
27
New
1
Increased
9
Reduced
4
Closed
4

Top Buys

Rank Stock Value
1
ESRX
Express Scripts Holding Company
ESRX
+$38.5M
2
VOD icon
Vodafone
VOD
+$4.66M
3
HUM icon
Humana
HUM
+$4.15M
4
JNJ icon
Johnson & Johnson
JNJ
+$4.06M
5
WMT icon
Walmart Inc
WMT
+$3.65M

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$41.3M
2
LMT icon
Lockheed Martin
LMT
+$29.3M
3
MSFT icon
Microsoft
MSFT
+$429K
4
TEVA icon
Teva Pharmaceuticals
TEVA
+$351K
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$316K

Sector Composition

Rank Sector Weight
1 Healthcare 37.48%
2 Consumer Staples 16.39%
3 Technology 16.33%
4 Financials 15.07%
5 Communication Services 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TEVA icon
26
Teva Pharmaceuticals
TEVA
$40.6B
– –
-6,700
Closed -$351K
1
2

Similar funds

LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
RPI
Railway Pension Investments London, United Kingdom $7.03B AUM 18.92% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
CWM
Circle Wealth Management Summit, New Jersey $7.02B AUM 19.32% 1-Year Est. Return
MNA
Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return
DE
Defiance ETFs New York $6.98B AUM
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
STA
Summit Trail Advisors New York $6.98B AUM 19.51% 1-Year Est. Return

ACR Alpine Capital Research's Q3 2014 Portfolio in Review

As of Q3 2014, ACR Alpine Capital Research held 27 positions worth $670M, up 2.5% from $654M the previous quarter. Its ten largest holdings account for 89% of the portfolio.

ACR Alpine Capital Research's Q3 2014 filing shows 1 new, 9 increased, 4 reduced and 4 closed positions. Its largest new stake was Express Scripts Holding Company: 541,005 shares worth $38.2M. The largest sale was Intel, an estimated $41.3M.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 30% a quarter earlier, followed by Consumer Staples and Technology.

  • ACR Alpine Capital Research's largest Q3 2014 buy was Express Scripts Holding Company: 541,005 shares worth $38.2M.
  • ACR Alpine Capital Research added most to Vodafone in Q3 2014, an estimated $4.66M increase.
  • ACR Alpine Capital Research's biggest Q3 2014 reduction was Intel, cutting an estimated $41.3M.
  • ACR Alpine Capital Research fully exited Teva Pharmaceuticals in Q3 2014, selling an estimated $351K.
  • ACR Alpine Capital Research's ten largest holdings make up 89% of its $670M portfolio in Q3 2014.
  • ACR Alpine Capital Research opened 1 new position and closed 4 in Q3 2014.
  • ACR Alpine Capital Research's portfolio value rose 2.5% quarter-over-quarter to $670M.

Based on ACR Alpine Capital Research's 13F filing for Q3 2014, filed 12 Nov 2014.